Molecular Diagnostics
Benchtop Immunoanalyzer Delivers Lab Quality Results for Cardiology, Intensive Care and Emergency Wards at POC
A compact immunoanalyzer with superior assay performance combines the accuracy of a full-scale lab analyzer with the flexibility of a mobile solution, making it an ideal analysis system for laboratories, hospitals and medical offices where fast quantitative results (with full-scale lab quality) are required at the point of care. More...24 Nov 2022
Blood Test Could Screen for Changes in Proteins Prior to Breast Cancer Diagnosis
Researchers have found changes in the levels of particular proteins in people’s blood up to two years before they were diagnosed with breast cancer. The study could form the basis of blood testing for people with a genetic predisposition or a family history of breast cancer to ensure the disease is diagnosed early when the chances of survival are greatest. More...23 Nov 2022
Tumor Biopsies Analysis Performed on Newly-diagnosed B-cell Neoplasms
Comprehensive genomic analyses of tumor biopsies from patients with newly-diagnosed germinal center B cell (GCB) diffuse large B cell/high grade B cell lymphoma (DLBCL/HGBL) have identified molecular subtypes predictive of inferior survival, which are characterized by somatic mutations that can be detected through clinical laboratory mutation analysis (CLMA). More...22 Nov 2022
Acute COVID-19 Infections Are Characterized by Elevated Blood Levels of IL-26
Increased systemic IL-26 was found to be associated with markers of hyperinflammation and tissue damage in patients with acute COVID-19, suggesting that it may be a potential target for diagnosis, monitoring, and therapy in this disease. More...22 Nov 2022
New Tool Assesses Cost of ctDNA Testing
Circulating tumor DNA (ctDNA) is a promising new biomarker with multiple potential applications in cancer care. Estimating total cost of ctDNA testing is necessary for reimbursement and implementation, but challenging because of variations in workflow. More...22 Nov 2022
Multiplex Vaginal Panel Identifies Three Distinct Conditions in One Hour
A new multiplexed PCR test detects DNA from organisms associated with three distinct conditions – bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis – from a single sample, aiding in more accurate diagnosis and antibiotic treatment regimens. More...22 Nov 2022
Novel Assay Enables Simultaneous Detection of SMA and SCID in Newborns
PerkinElmer, Inc. (Waltham, MA, USA) has received US FDA authorization for the marketing of its EONIS SCID-SMA assay kit for in vitro diagnostic (IVD) use by certified laboratories for the simultaneous detection of SMA and SCID in newborns. More...22 Nov 2022
Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
 (3) (1).png){kind=logo}
Pipette
Accumax Smart Series
Gold Member
Hybrid Pipette
SWITCH
In Other News
Simple Blood Test Could More Than Double Liver Cancer Detection Rate in High-Risk Population
First-Ever Saliva-Based Concussion Test to Be Available in 2023
AI Blood Test Detects Liver Cancer
Non-Invasive Saliva Test Predicts Future Risk for Alzheimer's
A Urine Test for Detection and Management of Cystic Fibrosis
Gene Signature Identifies Patients with Long-term Lyme Disease
Direct Real-Time PCR Protocol Detects Monkeypox Virus
Handheld Diagnostic Lab Offers POC Solution for Future Pandemics
Three-Protein Signature Blood Test Can Detect Undiagnosed Prediabetes
Novel Variant of Phosphorylated Tau Helps Fine Tune Early Diagnosis of Alzheimer’s Disease
POC Molecular Diagnostics Analyzer for Infectious Diseases Provides On-The-Spot Results
Rapid Test for G6PD Deficiency Runs on Toaster-Sized Instrument and Delivers Results in 15 Minutes at POC
New Urine Test Could Detect Childhood Kidney Disease Earlier than Current Assays
Breakthrough Diagnostic Technology Enables Quantitative Five-Minute Tests
World’s First Rapid Saliva-Based Pregnancy Test Set for Multi-Country Launch
Ultra-Fast Real-Time PCR Platform Could Revolutionize POC Molecular Diagnostics
Personalizing Whole Genome Sequencing Doubles Diagnosis of Rare Diseases
New Blood Test to Help Physicians Prevent Major Cardiovascular Events in Women with Lupus
Accurate Genetic Assay Identifies Human Neutrophil Antigen 2 Deficiency
Levels of the MicroRNA MiR-145 Predict Likelihood of Breast Cancer Recurrence
Nose Swabs May Distinguish Babies with RSV Needing Longer Intensive Care
New Immunoassay Specifically Measures Heart Attack-linked Blood Troponin Levels
A Procedure for Early Diagnosis of Pancreatic Cancer
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.